4//SEC Filing
BLECH ISAAC 4
Accession 0001127602-19-011917
CIK 0001472091other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 5:42 PM ET
Size
10.9 KB
Accession
0001127602-19-011917
Insider Transaction Report
Form 4
BLECH ISAAC
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-03-15−10,000→ 0 total→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2019-03-15+10,000→ 10,000 total
Footnotes (4)
- [F1]Vesting of RSUs granted to the Reporting Person on August 14, 2018.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
- [F3]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
- [F4]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0000905536
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 5:42 PM ET
- Size
- 10.9 KB